NEUCA S.A.

DB:7HD Stock Report

Market Cap: €919.1m

NEUCA Past Earnings Performance

Past criteria checks 4/6

NEUCA has been growing earnings at an average annual rate of 3%, while the Healthcare industry saw earnings growing at 10.6% annually. Revenues have been growing at an average rate of 8.7% per year. NEUCA's return on equity is 13.1%, and it has net margins of 1.3%.

Key information

3.0%

Earnings growth rate

2.4%

EPS growth rate

Healthcare Industry Growth15.7%
Revenue growth rate8.7%
Return on equity13.1%
Net Margin1.3%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How NEUCA makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

DB:7HD Revenue, expenses and earnings (PLN Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2412,3431611,1490
30 Jun 2412,1251651,1170
31 Mar 2411,9731551,0720
31 Dec 2311,8131461,0560
30 Sep 2311,8131281,0180
30 Jun 2311,6541089910
31 Mar 2311,4181259320
31 Dec 2211,2321378920
30 Sep 2210,9621488770
30 Jun 2210,7051638310
31 Mar 2210,3811618130
31 Dec 219,8641517770
30 Sep 219,5751447310
30 Jun 219,3291497140
31 Mar 218,9071426810
31 Dec 209,2451426830
30 Sep 208,9961486740
30 Jun 208,6951316570
31 Mar 208,7721306810
31 Dec 198,2721176500
30 Sep 198,0791166300
30 Jun 197,9411136330
31 Mar 197,7311006280
31 Dec 187,753956360
30 Sep 187,7001036320
30 Jun 187,643996250
31 Mar 187,645956110
31 Dec 177,485945980
30 Sep 177,433915900
30 Jun 177,321975820
31 Mar 177,2171075700
31 Dec 167,0771125520
30 Sep 166,9461085510
30 Jun 166,8971055400
31 Mar 166,9201055380
31 Dec 156,9461015390
30 Sep 157,0111135360
30 Jun 157,1001005360
31 Mar 156,957895250
31 Dec 146,569934980
30 Sep 146,199724720
30 Jun 145,897804450
31 Mar 145,759894280

Quality Earnings: 7HD has high quality earnings.

Growing Profit Margin: 7HD's current net profit margins (1.3%) are higher than last year (1.1%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 7HD's earnings have grown by 3% per year over the past 5 years.

Accelerating Growth: 7HD's earnings growth over the past year (26.3%) exceeds its 5-year average (3% per year).

Earnings vs Industry: 7HD earnings growth over the past year (26.3%) did not outperform the Healthcare industry 36.2%.

Return on Equity

High ROE: 7HD's Return on Equity (13.1%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/06 14:03
End of Day Share Price 2025/01/06 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

NEUCA S.A. is covered by 8 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Sylwia JaskiewiczDom Maklerski IDMSA
Cezary BernatekErste Group Bank AG
Lukasz KosiarskiIpopema Securities S.A.